Philips Healthcare will help Medtronic PLC' commercialize and develop the LungGPS patient management platform to help advanced imaging centers identify and manage patients with incidental pulmonary nodules within disparate hospital information systems.
Philips, Medtronic Seek To Navigate Lung Cancer Patients Toward Better Care
The two medtech leaders announced a partnership to develop and commercialize the LungGPS patient management platform, originally developed by superDimension and acquired by Medtronic in the Coviden merger. The patient and data management platform helps track and manage patients diagnosed with lung nodules, from identifying the nodules on images, through diagnosis, treatment, and long-term survivorship.
More from Diagnostic Imaging
More from Diagnostics
• By
The Cologuard Plus test has a sensitivity of 95% and a specificity of 94% for the detection of colorectal cancer; “unmatched accuracy,” according to Exact Sciences.
• By
The Visby Medical Women’s Sexual Health Test is the first over-the-counter test cleared by the US Food and Drug Administration to detect chlamydia, gonorrhea and trichomoniasis. It delivers results in about 30 minutes.
• By
A federal judge in Texas delivered what is most likely a fatal blow to the US FDA’s final rule, which would have regulated lab-developed tests as medical devices.